EUVIMEDEUVIMED entdecken
Historischer BeitragÜbersichtsarbeit

Discovery of Ximelagatran in an Historical Perspective

David Gustafsson

Seminars in Vascular Medicine · 01.01.2005 · 5 (03) · 227-234

DOI: 10.1055/s-2005-916161 ↗

Kurz gefasst

Historischer Beitrag in der Zeitschrift Seminars in Vascular Medicine, erschienen am 01.01.2005. Verfasst von David Gustafsson. Beteiligte Einrichtung: Department of Cardiovascular Pharmacology, AstraZeneca R&D, Mölndal, Sweden. Die Arbeit wurde bisher 6-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The oral direct thrombin inhibitor ximelagatran is the first oral anticoagulant since the introduction of the vitamin K antagonists in the early 1940s. A comparison of the discovery and early clinical development of the two classes of oral anticoagulants reveals some similarities but also several differences that illustrate the change in drug discovery over the last half century.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsAnticoagulantsAzetidinesBenzylaminesBlood CoagulationCattleClinical Trials as TopicDrug DesignHemorrhageHistory, 20th CenturyHumansMelilotusThrombinVitamin KWarfarin

Substanzen

AnticoagulantsAzetidinesBenzylaminesVitamin KximelagatranWarfarinThrombin

Autor:innen und Institutionen

  • Department of Cardiovascular Pharmacology, AstraZeneca R&D, Mölndal, Sweden.

Zitieren

APA

Gustafsson, D. (2005). Discovery of Ximelagatran in an Historical Perspective. Seminars in Vascular Medicine, 5(03), 227-234. https://doi.org/10.1055/s-2005-916161

Vancouver

Gustafsson D. Discovery of Ximelagatran in an Historical Perspective. Seminars in Vascular Medicine. 2005;5(03):227-234. doi:10.1055/s-2005-916161

BibTeX
@article{Gustafsson2005,
  author = {Gustafsson, David},
  title = {Discovery of Ximelagatran in an Historical Perspective},
  journal = {Seminars in Vascular Medicine},
  year = {2005},
  volume = {5},
  number = {03},
  pages = {227--234},
  doi = {10.1055/s-2005-916161}
}
Kostenlos starten →